Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (45)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Dudley, J.
Right arrow Articles by Chmiel, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dudley, J.
Right arrow Articles by Chmiel, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

American Journal of Epidemiology Vol. 142, No. 3: 323-330
Copyright © 1995 by The Johns Hopkins University School of Hygiene and Public Health


other

The Multicenter AIDS Cohort Study: Retention after 91/2 Years

Janice Dudley1, Shelia Jin1, Donald Hoover2, Sharon Metz3, Robert Thackeray4 and Joan Chmiel5

1Department of Epidemiology, School of Public Health, University of California Los Angeles, CA.
2Data Coordinating Center, School of Hygiene and Public Health, The Johns Hopkins University Baltimore, MD.
3Department of Epidemiology, School of Hygiene and Public Health, The Johns Hopkins University Baltimore, MD.
4Department of Infectious Disease and Microbiology, School of Public Health, University of Pittsburgh Pittsburgh, PA.
5Department of Preventive Medicine, Northwestern University Medical School Chicago, IL.

In a longitudinal, multicenter study of 4,954 men at risk for human immunodeficiency virus infection and acquired immunodeficiency syndrome, data from the first 9.5 years of follow-up (April 1984 through Septembe 1993) were used to determine differences between those who remained in the study and those who dropped out. Demographic variables (age, race, education, employment, and study center), health status (human immunodeficiency virus type 1 serostatus and depression), and behavioral characteristics (alcohol drinking, drug use, and anal-receptive intercourse) were analyzed. Strategies for promoting retention included having frequent contact with participants, generating trust, keeping participants well-informed, utilizing multiple resources for follow-up, and providing flexible methods of participation. After 9.5 years of follow-up, vital status was known for 4,385 (88.5%) of the participants. Results from multiple logistic regression showed that race, age, education, and smoking were each significantly associated with nonparticipation (p < 0.001). A high level of retention was maintained in this well-educated and highly motivated cohort of homosexual/bisexual men. Extensive follow-up methods may improve case-finding. Nonwhite race, younger age, less education, and smoking were important predictors of dropping out. These findings identify specific groups for targeting follow-up efforts to reduce potential bias due to dropout.

acquired immunodeficiency syndrome; cohort studies; epidemiologic methods; follow-up studies; HIV-1; multicenter studies


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am J EpidemiolHome page
P. L. Williams, R. Van Dyke, M. Eagle, D. Smith, C. Vincent, G. Ciupak, J. Oleske, G. R. Seage III, and for the PACTG 219C Team
Association of Site-specific and Participant-specific Factors with Retention of Children in a Long-term Pediatric HIV Cohort Study
Am. J. Epidemiol., June 1, 2008; 167(11): 1375 - 1386.
[Abstract] [Full Text] [PDF]


Home page
Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
L. Desquilbet, L. P. Jacobson, L. P. Fried, J. P. Phair, B. D. Jamieson, M. Holloway, J. B. Margolick, and for the Multicenter AIDS Cohort Study
HIV-1 Infection Is Associated With an Earlier Occurrence of a Phenotype Related to Frailty
J. Gerontol. A Biol. Sci. Med. Sci., November 1, 2007; 62(11): 1279 - 1286.
[Abstract] [Full Text] [PDF]


Home page
J. Epidemiol. Community HealthHome page
X. Li, H. Chu, J. E Gallant, D. R Hoover, W. J Mack, J. S Chmiel, and A. Munoz
Bimodal virological response to antiretroviral therapy for HIV infection: an application using a mixture model with left censoring.
J Epidemiol Community Health, September 1, 2006; 60(9): 811 - 818.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
C. F. Williams, D. Klinzman, T. E. Yamashita, J. Xiang, P. M. Polgreen, C. Rinaldo, C. Liu, J. Phair, J. B. Margolick, D. Zdunek, et al.
Persistent GB Virus C Infection and Survival in HIV-Infected Men
N. Engl. J. Med., March 4, 2004; 350(10): 981 - 990.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
L. Ahdieh-Grant, T. E. Yamashita, J. P. Phair, R. Detels, S. M. Wolinsky, J. B. Margolick, C. R. Rinaldo, and L. P. Jacobson
When to Initiate Highly Active Antiretroviral Therapy: A Cohort Approach
Am. J. Epidemiol., April 15, 2003; 157(8): 738 - 746.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
L. P. Jacobson, R. Li, J. Phair, J. B. Margolick, C. R. Rinaldo, R. Detels, and A. Munoz
Evaluation of the Effectiveness of Highly Active Antiretroviral Therapy in Persons with Human Immunodeficiency Virus using Biomarker-based Equivalence of Disease Progression
Am. J. Epidemiol., April 15, 2002; 155(8): 760 - 770.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
N. A. Hessol, M. Schneider, R. M. Greenblatt, M. Bacon, Y. Barranday, S. Holman, E. Robison, C. Williams, M. Cohen, and K. Weber
Retention of Women Enrolled in a Prospective Study of Human Immunodeficiency Virus Infection: Impact of Race, Unstable Housing, and Use of Human Immunodeficiency Virus Therapy
Am. J. Epidemiol., September 15, 2001; 154(6): 563 - 573.
[Abstract] [Full Text] [PDF]


Home page
J. Epidemiol. Community HealthHome page
M E Hellard, M I Sinclair, A B Forbes, and C K Fairley
Methods used to maintain a high level of participant involvement in a clinical trial
J Epidemiol Community Health, May 1, 2001; 55(5): 348 - 351.
[Abstract] [Full Text]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.